Pfizer COVID Shots 73% Protective in Kids Under 5
WEDNESDAY, Aug. 24, 2022 (HealthDay News) — Pfizer’s modified COVID-19 vaccine for use in children under 5 was 73% effective in shielding them from infection during the Omicron surge this spring, company data released Tuesday shows.The specially form…
Learn MoreAdenoviral-Based COVID-19 Vaccines May Up Short-Term CV Risk
TUESDAY, Aug. 23, 2022 (HealthDay News) — Adenoviral-based COVID-19 vaccines may be associated with increased incidence of myocardial infarction and pulmonary embolism among people aged younger than 75 years, according to a study published online Aug…
Learn MoreLas vacunas han reducido las tasas de infección con el VPH en las mujeres jóvenes de EE. UU.
LUNES, 22 de agosto de 2022 (HealthDay News) — En 2006, los médicos comenzaron a recomendar la primera vacuna contra el virus del papiloma humano (VPH), de frecuente transmisión sexual, que tenía el potencial de reducir el riesgo de ciertos tipos de …
Learn MoreFor Many, Myocarditis Risk Higher After SARS-CoV-2 Infection Than Vaccination
TUESDAY, Aug. 23, 2022 (HealthDay News) — The overall risk for myocarditis is higher after a positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test than after COVID-19 vaccination, according to a study published online Aug. 22 i…
Learn MoreHPV Vaccination, Infection Rates Examined in U.S. Women
TUESDAY, Aug. 23, 2022 (HealthDay News) — Human papillomavirus (HPV) vaccination appears to be associated with a reduction in HPV-16/18 infection prevalence among a recent birth cohort of vaccinated and unvaccinated 18- to 26-year-old women, accord…
Learn MorePfizer Asks FDA to Approve Omicron-Specific Booster Shot
MONDAY, Aug. 22, 2022 (HealthDay News) — Pfizer Inc. said Monday that it has asked the U.S. Food and Drug Administration to approve the emergency use of an updated booster shot that targets several versions of the omicron variant.Animal studies show …
Learn MorePfizer Asks FDA to Approve Omicron-Specific Booster Shot
MONDAY, Aug. 22, 2022 (HealthDay News) — Pfizer Inc. said Monday that it has asked the U.S. Food and Drug Administration to approve the emergency use of an updated booster shot that targets several versions of the Omicron variant.Animal studies show…
Learn MoreLos casos avanzados de cáncer de cuello uterino siguen en aumento entre las mujeres de EE. UU.
VIERNES, 19 de agosto de 2022 (HealthDay News) — Una nueva investigación apunta a un enigma en el cáncer de cuello uterino: aunque las tasas de enfermedad en etapa temprana han estado en descenso en Estados Unidos desde que se introdujo la vacuna con…
Learn MoreVaccines Have Slashed Rates of HPV Infection in Young American Women
MONDAY, Aug. 22, 2022 (HealthDay News) — Back in 2006, doctors began recommending the first vaccine for the common sexually transmitted human papillomavirus (HPV), with the shots carrying the potential to lower the risk of certain cancers.Now, a new …
Learn MoreLos países con cobertura universal de salud tuvieron unas mejores tasas de vacunación infantil en la pandemia
JUEVES, 18 de agosto de 2022 (HealthDay News) — Los países que están más cerca de lograr una cobertura universal de la salud tuvieron unos declives más pequeños en las vacunaciones infantiles de rutina durante la pandemia, revela un estudio reciente….
Learn More